Skip to main content

Table 1 Definitions and data sources of the QICH indicator set, 2007-2009.

From: Community healthcare in Israel: quality indicators 2007-2009

Healthcare quality indicators

Domain

Data sourcea

Target population

Asthma

   

Use of appropriate control medication for individuals with persistent asthma b

Percentage of individuals with persistent asthma who purchased at least three asthma control medications in three different months during the measurement year

Treatment

Pharmacy claims

5-56 years

Influenza vaccination for individuals with persistent asthma b

Percentage of individuals with persistent asthma who received the influenza vaccination during the winter months of the measurement year (plus two months of subsequent year)

Treatment

Pharmacy claims

5-56 years

Cancer screening

   

Breast cancer screening: Mammography

Percentage of women who had a mammogram during the past two years

Primary prevention

Test records

51-74 years

Colon cancer screening: Fecal occult blood test

Percentage of individuals who had a fecal occult blood test during the measurement yearc

Primary prevention

Laboratory results

50-74 years

Cardiovascular health

   

Blood pressure documentation

Percentage of individuals with blood pressure documentation

Primary prevention

Medical records

20-54 years - documentation during past five years;

55-74 years - documentation during measurement year

Blood pressure assessment

Percentage of individuals with adequate blood pressure control (≤ 140/90 mmHg)

Primary prevention

Medical records

20-54 years - documentation during past five years;

55-74 years - documentation during measurement year

Body mass index (BMI) documentation

• Percentage of individuals with BMI documentation - adolescents

• Percentage of individuals with BMI documentation - adults

Primary prevention

Medical records

14-18 years - documentation during past three years;

20-64 years - documentation during past five years;

65-74 years - documentation of weight during the measurement year and height during the past five years

Cholesterol documentation

Percentage of individuals with cholesterol documentation

Primary prevention

Laboratory results

35-54 years - documentation during past five years;

55-74 years - documentation during measurement year

Cholesterol assessment

Percentage of individuals with adequate low-density lipoprotein cholesterol control (≤ 130 mg/dL)

Primary prevention

Laboratory results

35-54 years - documentation during past five years;

55-74 years - documentation during measurement year

Treatment with statins and other low-density lipoprotein (LDL) modifying medications following a coronary intervention d

Percentage of individuals following a coronary event who purchased at least three LDL-modifying medications in three different months during the measurement year

Treatment

Pharmacy claims, Hospital procedures

35-74 years

Treatment with angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) following a coronary intervention d

Percentage of individuals following a coronary event who purchased at least three ACEI/ARB medications in three different months during the measurement year

Treatment

Pharmacy claims, Hospital procedures

35-74 years

Treatment with beta blockers following a coronary intervention d

Percentage of individuals following a coronary event who purchased at least three ACEI/ARB medications in three different months during the measurement year

Treatment

Pharmacy claims, Hospital procedures

35-74 years

Cholesterol assessment following a coronary intervention d

Percentage of individuals following a coronary event with adequate cholesterol control (≤ 100 mg/dL) during the measurement year

Effectiveness of care

Laboratory results, Hospital procedures

35-74 years

Child health

   

Anemia screening in infants

Percentage of children who had a hemoglobin test during the measurement year

Primary prevention

Laboratory results

1 year olds

Diabetes

   

Blood pressure documentation

Percentage of patients with diabetes mellitus with blood pressure documentation during the measurement year

Treatment

Laboratory results

18+ years

Body mass index (BMI) documentation

Percentage of patients with diabetes mellitus with BMI documentation

Treatment

Medical records

18+ years - documentation of weight during the measurement year and height over the past five years

Cholesterol documentation

Percentage of patients with diabetes mellitus with cholesterol documentation during the measurement year

Treatment

Laboratory results

All ages

Eye care documentation

Percentage of patients with diabetes mellitus with documentation of an eye examination during the measurement year

Treatment

Medical records

All ages

Glycemic control documentation

Percentage of patients with diabetes mellitus with glycemic control (HbA1c) documentation during the measurement year

Treatment

Laboratory results

All ages

Kidney function documentation

Percentage of patients with diabetes mellitus with microalbuminurea documentation during the measurement year

Treatment

Laboratory results

All ages

Influenza vaccination

Percentage of patients with diabetes mellitus who received the influenza vaccination during the winter months of the measurement year (plus two months of subsequent year)

Treatment

Pharmacy claims

5+ years

Blood pressure assessment

Percentage of patients with diabetes mellitus with adequate blood pressure control (≤ 130/80 mmHg) during the measurement year

Effectiveness of care

Medical records

18+ years

Cholesterol assessment

Percentage of patients with diabetes mellitus with adequate low-density lipoprotein cholesterol control (≤ 100 mg/dL) during the measurement year

Effectiveness of care

Laboratory results

All ages

Glycemic control assessment

Percentage of diabetics with adequate glycemic control (HbA1c ≤ 7%) during the measurement year

Effectiveness of care

Laboratory results

All ages

Assessment of inadequate glycemic control

Percentage of patients with diabetes mellitus with inadequate glycemic control (HbA1c > 9%) during the measurement year

Effectiveness of care

Laboratory results

All ages

Treatment with insulin for individuals with inadequate glycemic control

Percentage of patients with diabetes mellitus with inadequate glycemic control (HbA1c > 9%) and purchased insulin at least once during the measurement year

Effectiveness of care

Laboratory results, Pharmacy claims

All ages

Immunizations for older adults

   

Influenza vaccination for older adults

Percentage of older adults who received the influenza vaccination during the winter months of the measurement year (plus two months of subsequent year)

Primary prevention

Pharmacy claims

65+ years

  1. BMI, body mass index; LDL, low density lipoproteins; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; HbA1c, glycated hemoglobin; QICH, National Program for Quality Indicators in Community Healthcare in Israel
  2. aAll data were collected from each MCO's electronic records. Numerator and denominator data for each measure were collected by the National QICH project to create the national rate.
  3. b Persistent asthma is defined by asthma medication purchases. These medications include control medication (immunomodulators, inhaled corticosteroids, leukotriene modifiers, long-acting beta-2 agonists, methylxanthines, mast cell stabilizers), as well as relief medications (short-acting beta-2 agonists, anticholinergics).
  4. c Excluding those who underwent a colonoscopy during the past five years.
  5. dA coronary intervention is defined as having undergone coronary artery bypass surgery or cardiac catheterization during the past five years.